Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indacaterol acetate dose finding in pediatric asthma
NCT02892019Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of indacaterol in asthma, sponsored by Novartis. Started Apr 2017; status: completed.
02
Drugs
indacaterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02892019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02892019.